Look for:

Our offer for

PHARMING GROUP N.V.


ISIN:
NL0010391025
WKN:
518940

2024/07/11 16:25:28
Price
0.8045 EUR
Difference 2.35% (0.02)

General attributes

ISINNL0010391025
SymbolPHARM
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)542 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)0.801 EUR (1,250)
Ask (Ask size)0.8085 EUR (1,240)
Open0.806 EUR
High0.806 EUR
Low0.796 EUR
Close (prev. day)0.786 EUR
VWAP0.80452 EUR
Volume (pcs)34,895
Trading volume28,073.88
Number of trades11
Last size2,071

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: PHARMING GROUP N.V.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/07/11 16:25:28
Price
0.8045 EUR
Difference 2.35% (0.02)

General attributes

ISINNL0010391025
SymbolPHARM
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)542 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)0.801 EUR (1,250)
Ask (Ask size)0.8085 EUR (1,240)
Open0.806 EUR
High0.806 EUR
Low0.796 EUR
Close (prev. day)0.786 EUR
VWAP0.80452 EUR
Volume (pcs)34,895
Trading volume28,073.88
Number of trades11
Last size2,071

Performance and Risk

6m1Y3Y
Perf (%)-34.93%-27.02%-18.40%
Perf (abs.)-0.42-0.29-0.18
Beta1.240.800.79
Volatility32.5533.3248.49
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.7683 EUR (44,055)
Ø price 30 days | Ø volume 30 days (pcs.)0.7732 EUR (27,103)
Ø price 100 days | Ø volume 100 days (pcs.)0.9062 EUR (44,178)
Ø price 250 days | Ø volume 250 days (pcs.)1.0337 EUR (45,881)
YTD High | date1.2200 EUR (2024/01/09)
YTD Low | date0.7380 EUR (2024/06/17)
52 Weeks High | date1.3110 EUR (2023/09/18)
52 Weeks Low | date0.7380 EUR (2024/06/17)

All listings for PHARMING GROUP N.V.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/07/1116:250.8045 EUR0.0311
Stuttgart2024/07/1115:260.798 EUR0.008
Munich2024/07/1108:160.7815 EUR0.001
London Stock Exchange European Trade Reporting2024/07/1117:300.801 EUR0.002
Frankfurt2024/07/1108:060.775 EUR0.001
FINRA other OTC Issues2024/07/0517:530.85 USD0.001
Euronext Amsterdam2024/07/1117:350.805 EUR3.071,057
Duesseldorf2024/07/1108:100.7795 EUR0.001
Berlin2024/07/1108:160.7815 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=14223&ID_TYPE_IMAGE_LOGO=2

Contact Details

PHARMING GROUP NV
- -
Darwinweg 24 - 2333 CR Leiden
Telefon: +31-71-524-74-00
Fax: +
E-mail: info@pharming.com

PDF Downloads

Company report: PHARMING GROUP N.V.PDF Download

Company Profile

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Members of Management Board

Sijmen de VriesChairman of Managing Board
Anurag RelanMember of Executive Committee
Jeroen WakkermanMember of Executive Committee
Mireille SandersMember of Executive Committee
Ruud van OutersterpMember of Executive Committee
Stephen ToorMember of Executive Committee

Board of directors

Richard PetersChairman of Supervisory Board
Jabine T. M. van der MeijsMember of Supervisory Board
Mark PykettMember of Supervisory Board
Barbara YanniMember of Supervisory Board
Deborah JornMember of Supervisory Board
Leonard KruimerMember of Supervisory Board
Steven BaertMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer